Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
Bruker Corporation (BRKR)
Last bruker corporation earnings: 10/31 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.bruker.com/investors/default.aspx
Company Research
Source: Business Wire
The new platform delivers unmatched quantitation, robustness, and throughput to support clinical translation of spatial proteomics assays ORLANDO, Fla.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced the launch of CellScape™ XR, a next-generation spatial proteomics platform designed to advance the development of diagnostic and prognostic assays by delivering unprecedented quantitative performance, robustness, and flexibility. CellScape XR addresses a critical bottleneck in translational research by enabling high-throughput, reproducible spatial proteomics at a scale and rigor required for translational and clinical applications.As spatial proteomics moves from discovery to translational research and to diagnostic development, researchers face increasing demands for assay reproducibility, standardization, quantitative confidence, and throughput across large clinical cohorts. CellScape XR incorporates advances in optics, fluidics, and protocols to specifically meet thes
Show less
Read more
Impact Snapshot
Event Time:
BRKR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BRKR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BRKR alerts
High impacting Bruker Corporation news events
Weekly update
A roundup of the hottest topics
BRKR
News
- Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic ApplicationsBusiness Wire
- Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease BiologyBusiness Wire
- Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological SpectrumBusiness Wire
- 3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players [Yahoo! Finance]Yahoo! Finance
- Bruker (NASDAQ:BRKR) had its price target lowered by analysts at TD Cowen from $53.00 to $43.00. They now have a "hold" rating on the stock.MarketBeat
BRKR
Earnings
- 2/12/26 - Miss
BRKR
Sec Filings
- 2/27/26 - Form S-8
- 2/27/26 - Form S-8
- 2/27/26 - Form 10-K
- BRKR's page on the SEC website